Table 1.
OS | |||||
---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | ||||
HR (95% CI) | P | HR (95% CI) | P | ||
E2F8 expression | 1.108 (0.481-2.556) | 0.809 | |||
Age, years (continuous) | 1.003 (0.974-1.033) | 0.837 | |||
FIGO stage | 1.844 (1.276-2.663) | 0.001 | 1.816 (1.258-2.622) | 0.001 | |
cell type | 1.026 (0.720-1.461) | 0.889 | |||
Lymph node metastasis | 1.939 (0.977-3.847) | 0.054 | |||
Lymphovascular invasion | 1.385 (0.658-2.915) | 0.39 | |||
Recurrence | 7.545 (3.535-16.103) | 0.000000017 | 7.823 (3.605-16.973) | 0.000000195 | |
tumor size | 1.365 (0.849-2.195) | 0.199 |
OS, overall survival; HR, hazard ratio; FIGO, The International Federation of Gynecology and Obstetrics